117 related articles for article (PubMed ID: 16636244)
1. Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions.
Arsenault ME; Prévost C; Lescault A; Laberge C; Puymirat J; Mathieu J
Neurology; 2006 Apr; 66(8):1248-50. PubMed ID: 16636244
[TBL] [Abstract][Full Text] [Related]
2. Replication inhibitors modulate instability of an expanded trinucleotide repeat at the myotonic dystrophy type 1 disease locus in human cells.
Yang Z; Lau R; Marcadier JL; Chitayat D; Pearson CE
Am J Hum Genet; 2003 Nov; 73(5):1092-105. PubMed ID: 14574643
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetics and genetic testing in myotonic dystrophy type 1.
Savić Pavićević D; Miladinović J; Brkušanin M; Šviković S; Djurica S; Brajušković G; Romac S
Biomed Res Int; 2013; 2013():391821. PubMed ID: 23586035
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and genetic spectrum of a multicenter Chinese cohort with myotonic dystrophy type 1.
Zhong H; Zeng L; Yu X; Ke Q; Dong J; Chen Y; Luo L; Chang X; Guo J; Wang Y; Xiong H; Liu R; Liu C; Wu J; Lin J; Xi J; Zhu W; Tan S; Liu F; Lu J; Zhao C; Luo S
Orphanet J Rare Dis; 2024 Mar; 19(1):103. PubMed ID: 38454488
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and Management of Myotonic Dystrophy Type 1.
Hartman J; Patki T; Johnson NE
JAMA; 2024 Apr; 331(14):1227-1228. PubMed ID: 38466298
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic uplift through the implementation of short tandem repeat analysis using exome sequencing.
Yoon JG; Lee S; Cho J; Kim N; Kim S; Kim MJ; Kim SY; Moon J; Chae JH
Eur J Hum Genet; 2024 May; 32(5):584-587. PubMed ID: 38308084
[TBL] [Abstract][Full Text] [Related]
7. [Hans Steinert: 100 years of myotonic dystrophy].
Steinberg H; Wagner A
Nervenarzt; 2008 Aug; 79(8):961-2, 965-70. PubMed ID: 18566789
[TBL] [Abstract][Full Text] [Related]
8. A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat.
Boucher CA; King SK; Carey N; Krahe R; Winchester CL; Rahman S; Creavin T; Meghji P; Bailey ME; Chartier FL
Hum Mol Genet; 1995 Oct; 4(10):1919-25. PubMed ID: 8595416
[TBL] [Abstract][Full Text] [Related]
9. Localisation of the myotonic dystrophy locus to 19q13.2-19q13.3 and its relationship to twelve polymorphic loci on 19q.
Harley HG; Walsh KV; Rundle S; Brook JD; Sarfarazi M; Koch MC; Floyd JL; Harper PS; Shaw DJ
Hum Genet; 1991 May; 87(1):73-80. PubMed ID: 2037285
[TBL] [Abstract][Full Text] [Related]
10. Ethnic distribution of myotonic dystrophy gene.
Ashizawa T; Epstein HF
Lancet; 1991 Sep; 338(8767):642-3. PubMed ID: 1679186
[No Abstract] [Full Text] [Related]
11. Highly unstable sequence interruptions of the CTG repeat in the myotonic dystrophy gene.
Musova Z; Mazanec R; Krepelova A; Ehler E; Vales J; Jaklova R; Prochazka T; Koukal P; Marikova T; Kraus J; Havlovicova M; Sedlacek Z
Am J Med Genet A; 2009 Jul; 149A(7):1365-74. PubMed ID: 19514047
[TBL] [Abstract][Full Text] [Related]
12. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy.
Timchenko LT; Miller JW; Timchenko NA; DeVore DR; Datar KV; Lin L; Roberts R; Caskey CT; Swanson MS
Nucleic Acids Res; 1996 Nov; 24(22):4407-14. PubMed ID: 8948631
[TBL] [Abstract][Full Text] [Related]
13. Myotonic dystrophy: diagnosis, management and new therapies.
Turner C; Hilton-Jones D
Curr Opin Neurol; 2014 Oct; 27(5):599-606. PubMed ID: 25121518
[TBL] [Abstract][Full Text] [Related]
14. Early-onset dystrophia myotonica. Evidence supporting a maternal environmental factor.
Harper PS; Dyken PR
Lancet; 1972 Jul; 2(7767):53-5. PubMed ID: 4113301
[No Abstract] [Full Text] [Related]
15. Genealogical reconstruction of myotonic dystrophy in the Saguenay-Lac-Saint-Jean area (Quebec, Canada).
Mathieu J; De Braekeleer M; Prévost C
Neurology; 1990 May; 40(5):839-42. PubMed ID: 2330114
[TBL] [Abstract][Full Text] [Related]
16. Myotonic dystrophy.
Thornton CA
Neurol Clin; 2014 Aug; 32(3):705-19, viii. PubMed ID: 25037086
[TBL] [Abstract][Full Text] [Related]
17. The myotonic dystrophies: molecular, clinical, and therapeutic challenges.
Udd B; Krahe R
Lancet Neurol; 2012 Oct; 11(10):891-905. PubMed ID: 22995693
[TBL] [Abstract][Full Text] [Related]
18. Studying a Drug-like, RNA-Focused Small Molecule Library Identifies Compounds That Inhibit RNA Toxicity in Myotonic Dystrophy.
Rzuczek SG; Southern MR; Disney MD
ACS Chem Biol; 2015 Dec; 10(12):2706-15. PubMed ID: 26414664
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of muscular dystrophies: a systematic literature review.
Theadom A; Rodrigues M; Roxburgh R; Balalla S; Higgins C; Bhattacharjee R; Jones K; Krishnamurthi R; Feigin V
Neuroepidemiology; 2014; 43(3-4):259-68. PubMed ID: 25532075
[TBL] [Abstract][Full Text] [Related]
20. The problem of anticipation in pedigrees of dystrophia myotonica.
PENROSE LS
Ann Eugen; 1948 Apr; 14(2):125-32. PubMed ID: 18863976
[No Abstract] [Full Text] [Related]
[Next] [New Search]
